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Bart–Pumphrey syndrome (BPS) is an autosomal dominant disorder characterized by sensorineural hearing loss,
palmoplantar keratoderma, knuckle pads, and leukonychia, which show considerable phenotypic variability. The
clinical features partially overlap with Vohwinkel syndrome and Keratitis–Ichthyosis–Deafness syndrome, both
disorders caused by dominant mutations in the GJB2 gene encoding the gap junction protein connexin-26, sug-
gesting an etiological relationship. We report here a novel GJB2 mutation N54K segregating in a family with BPS,
which was not detected in 110 control individuals of Northern European ancestry. This non-conservative missense
mutation lies within a cluster of pathogenic GJB2 mutations affecting the evolutionary conserved ﬁrst extracellular
loop of Cx26 important for docking of connexin hemichannels and voltage gating. Immunostaining of Cx26 in
lesional palmar and knuckle skin was weak or absent, although its adnexal expression appeared normal and the
punctate membrane staining of Cx26 and other epidermal connexins was not altered. Nevertheless, the widespread
immunostaining of Cx30 throughout the spinous cell layers suggested a compensatory overexpression. Our re-
sults emphasize that pleiotropic GJB2 mutations are responsible for at least 5 overlapping dermatological dis-
orders associated with syndromic hearing loss and cover a wide range of severity and organ involvement.
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Thirty-seven years ago in the New England Journal of Med-
icine, the dermatologist Bart and otolaryngologist Pum-
phrey described a new autosomal dominant syndrome
characterized by knuckle pads, leukonychia, palmoplantar
keratoderma (PPK), and deafness segregating in a 6-
generation family, and disputed whether this complex phe-
notype could be a monogenic defect with pleiotropic
expression (Bart and Pumphrey, 1967). Recognized as a
distinct form of ectodermal dysplasia and syndromic PPK
(OMIM#149200), several families and sporadic cases have
been reported since, often with a striking and partially age-
dependent variability in clinical features between family
members (Schwann, 1963; Crosby and Vidurrizaga, 1976;
Crosti et al, 1983; Ramer et al, 1994; Kose and Baloglu,
1996).
The coexistence of prelingual sensorineural hearing loss
(SNHL) and an inherited disorder of cornification is relatively
rare. Only 11 families with SNHL/PPK have been reported to
date, none of which developed knuckle pads, leukonychia
or other abnormalities (Bititci, 1975; Frentz et al, 1976;
Hatamochi et al, 1982; Sharland et al, 1992; Fit-
zgerald and Verbov, 1996; Richard et al, 1998; Sevior
et al, 1998; Heathcote et al, 2000; Kelsell et al, 2000; Martin
et al, 2000; Rouan et al, 2001; Uyguner et al, 2002). Mo-
lecular studies revealed in three of these families with focal
plaques of PPK a common point mutation (A7445G) in the
extrachromosomal mitochondrial genome (mtDNA) (Sevior
et al, 1998; Martin et al, 2000), while point mutations in the
connexin-26 (Cx26) gene, GJB2, on chromosome 13q11–
q12 were detected in five families with variable forms of
PPK (Richard et al, 1998; Heathcote et al, 2000; Kelsell et al,
2000; Rouan et al, 2001; Uyguner et al, 2002). More often,
PPK and SNHL are associated with other distinct features,
such as digital circular constriction bands and pseudoain-
hum in autosomal dominant Vohwinkel syndrome, also
known as mutilating keratoderma (OMIM#124500) (Vohwin-
kel, 1929). In Keratitis–Ichthyosis–Deafness syndrome
(KIDS; OMIM#148210), PPK and SNHL are accompanied
by corneal defects and neovascularization, follicular hyper-
keratoses, generalized thickening of the skin or symme-
trically distributed erythematous and hyperkeratotic
plaques. In addition, an increased susceptibility to muco-
cutaneous infections and squamous cell carcinoma has
been noted (Caceres-Rios et al, 1996). The rare occurrence
of partial leukonychia or knuckle pads in KIDS (Jurecka
et al, 1985; Shiraishi et al, 1994; Kone-Paut et al, 1998)
emphasizes the clinical overlap with Bart–Pumphrey syn-
drome (BPS). The molecular cause of both Vohwinkel and
KID syndrome are distinct germline mutations in GJB2
Abbreviations: BPS, Bart–Pumphrey syndrome; Cx26, gap junction
protein connexin-26; PPK, palmoplantar keratoderma; SNHL, sen-
sorineural hearing loss
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encoding the gap junction protein connexin-26 (Cx26) (Ma-
estrini et al, 1999; Kelsell et al, 2000; Richard et al, 2002; van
Steensel et al, 2002). Therefore, we have investigated a
family with BPS and report here a novel pathogenic GJB2
(Cx26) mutation, confirming that BPS stems from an un-
derlying defect in an epithelial connexin gene. Our results
broaden the phenotypic spectrum of Cx26 mutations and
illustrate their intriguing pleiotropic effects.
Results
Clinical features We studied a multigeneration BPS family
originating in Poland (Fig 1). All affected family members,
including the maternal grandmother and uncle, consistently
presented with congenital deafness and developed diffuse,
sharply demarcated thickening of the skin of palms and
soles during early childhood (Fig 2). In the proband, an au-
diogram at 24 y of age demonstrated profound bilateral
SNHL with normal middle ear function. The PPK had locally
an almost punctate surface reminiscent of VS, and was
most profound over the heels and in interphalangeal folds,
resulting there in the formation of hard, hyperkeratotic
bands (Fig 2b, c). Before puberty, individuals II-1 and III-1
had developed fixed, hyperkeratotic plaques with a verru-
cous surface over the metacarpo- and interphalangeal
joints (knuckle pads) that regressed over time in II-1 (Fig 2a,
d ). III-1 had leukonychia of all nails, which was also present,
albeit to a much lesser degree, in II-1 (Fig 2a, d). The nails of
other affected family members were reportedly normal.
There was no evidence for abnormalities involving mucous
membranes, hair, sweat glands and vision or any other or-
gan manifestations. Light microscopic examination (Fig 2e)
of skin biopsies from the left palm and a metacarpal knuckle
pad of individual III-1 revealed similar pathological features,
including massive orthokeratotic hyperkeratosis without ev-
idence for retained nuclei, hypergranulosis, acanthosis, and
papillomatosis. Epidermal gap junctions appeared normal
on electron microscopic evaluation (Fig 2f ).
A novel GJB2 mutation, N54K, in BPS Mutation analysis
of GJB2 revealed in both affected individuals II-1 and III-1 a
heterozygous C to A substitution at nucleotide 162 (from the
ATG start site) in codon 54. This point mutation is predicted
to lead to a non-conservative replacement of asparagine 54
(AAC) with a negatively charged lysine (AAA) (N54K, Fig 1a)
in the first extracellular loop of Cx26. The co-segregation of
N54K with BPS in the proband’s family was confirmed by
pyrosequencing (data not shown), and the mutation was
excluded in 110 unrelated controls of Northern European
origin without evidence for skin disorders or hearing loss by
pyrosequencing or direct DNA sequencing. These results,
together with data compiled from thousands of individuals
tested for GJB2 variants worldwide (see The Connexin-
Deafness Homepage), evidently excluded the possibility of
N54K being a non-consequential sequence polymorphism
and strongly support the causative role of N54K in BPS.
Sequence alignment of human Cx26 with the other 19
members of the connexin family in man and in other species
demonstrated that asparagine is almost invariably present
at this position in the first extracellular loop and evolutionary
highly conserved (Fig 1b).
To investigate if sequence variants in other epidermally
expressed connexin genes might modify the clinical phe-
notype in BPS, we also screened the genes encoding Cx30,
Cx30.3, Cx31, Cx31.1, and Cx43. III-1 was heterozygous for
the silent polymorphism N119N in GJB3 (Cx31) with a fre-
quency of 3% for the minor thymidine allele in a control
population (Richard et al, 2000), but no other sequence
aberrations were found.
Aberrant connexin expression in lesional epidermis To
assess the in vivo effects of mutation N54K on the cutane-
ous gap junction system, we performed immunohistochem-
ical analyses of Cx26, Cx30, and Cx43 on frozen sections of
palmar and knuckle lesional skin of the proband. Similar to
normal interfollicular epidermis, Cx26 immunostaining was
absent in the hyperkeratotic and acanthotic knuckle epi-
dermis (Fig 3a). In palmar skin, Cx26 staining was irregular
and weak, limited to a few foci in the spinous layers (Fig 3d ).
Nonetheless, epithelial cells of eccrine sweat glands and
sweat ducts demonstrated a distinct, punctate, plasma
membrane staining of Cx26, which widely overlapped with
that of Cx30 (Fig 3f ) as in normal control skin. Epidermal
keratinocytes surrounding the eccrine sweat ducts showed
focal points of co-localization of both Cx43 and Cx26 in
lesional skin (Fig 3g). There was no detectable cytoplasmic
accumulation of Cx26 nor Cx30 or Cx43 in the cells, sug-
gesting that the mutant Cx26 might be either rapidly de-
graded or properly transferred to the cell membranes. In
contrast to Cx26, Cx30 staining was much more intense
and widespread compared with normal skin and extended
to the spinous cell layers (Fig 3b). The distribution of Cx43
appeared normal with a strong punctate membrane staining
throughout the spinous and granular layers as well as weak
staining in basal keratinocytes (Fig 3c). These observations
suggested that mutation N54K resulted in reduced epider-
mal Cx26 expression with compensatory overexpression of
Cx30 albeit it did apparently not interfere with the formation
of Cx30 and Cx43-containing gap junctions.
Discussion
Human connexin 26 belongs to a multigenic family of 20
structural proteins forming gap junctions, clusters of inter-
cellular channels that permit the diffusional exchange of
ions and small metabolites between adjoining cells (Will-
ecke et al, 2002). This direct intercellular communication
system plays an important role for control and coordination
of tissue morphogenesis, differentiation, and growth, and
fulfills a multitude of tissue-specific functions. Cx26 is wide-
ly expressed in most tissues of the human body, including
the ectodermally derived epithelia of cochlea, cornea, and
skin (Salomon et al, 1994; Forge et al, 1999; Lucke et al,
1999; Richard et al, 2002). The complete loss of Cx26 pro-
tein or its function due to recessive mutations in GJB2 is
the singlemost common cause of non-syndromic SNHL in
man (Rabionet et al, 2002). In mice, the targeted ablation of
Cx26 in the inner ear (Cohen-Salmon et al, 2002), as well as
the transgenic expression of a dominant-negative Cx26
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Figure 1
Mutation analysis and sequence conservation. (a) Top: pedigree of the Bart–Pumphrey syndrome (BPS) family demonstrating the intrafamilial
variability. The clinical features of affected individuals are listed below the standard symbols. HL, hearing loss; PPK, palmoplantar keratoderma; KP,
knuckle pads; L, leukonychia. The arrow indicates that the proband, participating family members are labeled by asterisks. Bottom: sequence
chromatograms of GJB2 from affected (II-1 and III-1) and unaffected (II-2) family members depicting the heterozygous transversion 162C ! A
(arrow) at codon 54 encoding lysine instead of asparagine (N54K). (b) Amino acid sequence alignment of all 20 human connexins and 9 different
mammalian Cx26 homologues across the first extracellular loop. The gray box highlights evolutionary conservation of asparagine 54 in Cx26 and its
homologues. Other dominant GJB2 mutations and their phenotypes are shown atop the alignment. Red: Bart–Pumphrey syndrome; blue: Keratitis–
Ichthyosis–Deafness syndrome; Green: Palmoplantar keratoderma and deafness; black: non-syndromic sensorineural hearing loss.
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mutation (R75W) (Kudo et al, 2003), revealed a progressive
degeneration of the sensory hair cells ensuing from de-
formed supporting cells and loss of the tunnel of Corti,
possibly due to disturbed cortilymph homeostasis. These
findings vividly illustrate the essential function of Cx26 for
the auditory process in the inner ear, though different con-
nexin proteins apparently compensate for Cx26 in all other
organs, including the skin. The latter organ utilizes up to 10
different connexin proteins (Di et al, 2001). Under normal
circumstances Cx26 expression is limited to the palmo-
plantar epidermis, sweat glands and ducts, and hair folli-
cles. Upregulation of Cx26 in response to wounding, tape
stripping, treatment with retinoids and in hyperproliferative
epidermal disorders such as psoriasis (Masgrau-Peya et al,
1997; Labarthe et al, 1998; Lucke et al, 1999; Coutinho et al,
2003), however, implicates Cx26 in growth regulation, mi-
gration, and differentiation of keratinocytes. Although the
mere loss of Cx26 is not sufficient to produce a skin disorder,
autosomal dominant mutations of the Cx26 gene may man-
ifest with various cutaneous and extracutaneous findings,
perhaps due to their dominant-negative effect on wild-type
Cx26 and other connexins as determined in vitro (Richard
et al, 1998; Martin et al, 1999; Rouan et al, 2001; Forge et al,
2003; Marziano et al, 2003) and in vivo (Bakirtzis et al, 2003).
In this study, we demonstrate that BPS is the fifth defined
phenotype attributable to dominant GJB2 mutations. We
report a novel pathogenic GJB2 mutation (162C4A) sub-
stituting a highly conserved asparagine with lysine (N54K) in
the first extracellular loop of Cx26, which leads to congen-
ital SNHL, PPK, prominent knuckle pads, and leukonychia.
Thus, 37 y after the recognition of this rare syndrome, our
results provide molecular evidence supporting Bart and
Pumphrey’s hypothesis of a single genetic defect with
pleiotropic expression. It remains to be seen, however, if the
amino acid replacement, N54K, is consistently associated
with a BPS phenotype, in analogy to mutation D66H in
Vohwinkel syndrome, or if BPS may be caused by different
GJB2 mutations, as is the case in KID syndrome.
In fact, the range of phenotypic presentations of autos-
omal dominant GJB2 mutations is intriguing. They form an
allelic series including non-syndromic SNHL (W44C, W44S,
R75W, R75Q, D179N, R184Q, and C202F), SNHL asso-
ciated with diffuse or transgredient PPK (E42del, G59R,
R75W, and R75Q) Vohwinkel syndrome (D66H), KID syn-
drome (D50N, D50Y), and now BPS (N54K) (Richard, 2003a)
(see also The Connexin-Deafness Homepage). Tissue
involvement and severity span a broad range from
non-syndromic SNHL affecting the inner ear alone to the
multisystemic disorder KIDS syndrome, which may affect
cochlea (SNHL), skin (PPK, erythrokeratoderma), cornea
(keratitis, corneal neovascularization), hair follicles (hypo-
and atrichosis), teeth and nails, and increases the risk for
squamous cell carcinoma (Caceres-Rios et al, 1996). Hence
it seems conceivable that Cx26 gene mutations may play
a pathogenic role in yet other disorders with partially
overlapping features, such as autosomal recessive Heimler
Figure 2
Clinical features of Bart–Pumphrey
syndrome (BPS). (a) III-1. 24-y-old man
with leukonychia, hyperkeratotic, verruci-
form plaques over metacarpo- and inter-
phalangeal joints (knuckle pads) and (b)
diffuse palmoplantar keratoderma with
formation of hard, keratotic bands in the
interphalangeal folds. (c) II-1. 58-y-old
mother of III-1. Note the rough, grainy sur-
face of the plantar keratoderma and (d) the
lack of knuckle pads and very discrete
leukonychia of the right hand. (e). Photo-
micrograph of a skin biopsy of a knuckle
pad (H&E stain) shows compact ortho-
keratotic hyperkeratosis, hypergranulosis,
and acanthosis of the epidermis. ( f )
Transmission electron micrograph demon-
strating a normal-appearing gap junction
plaque between granular keratinocytes.
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syndrome (OMIM 234580) characterized by SNHL, leuk-
onychia and other nail findings, autosomal-dominant SNHL
associated with nail dystrophy (OMIM 124480) or, less likely,
leukonychia totalis hereditaria (OMIM 151,600) and familial
idiopathic knuckle pads (Paller and Hebert, 1986).
With the exception of a few KIDS mutations in the N-
terminus (Richard et al, 2002), all pathogenic GJB2 muta-
tions with a complex phenotype cluster in and around the
evolutionary conserved first extracellular loop (E1) of Cx26
(Fig 1b). This finding strongly attests to the functional im-
portance of this protein domain, which has been shown to
play a fundamental role for the assembly of connexon
hemichannels, connexon–connexon interactions, voltage
gating, and channel permeability (Rubin et al, 1992; White
et al, 1995; Oshima et al, 2003). Differences in position and
character of the listed mutations in E1 may translate into
different pathophysiological consequences, which perhaps
could be the basis for their remarkable phenotypic diversity.
For example, the substitution of any of the three conserved
extracellular cysteine residues in E1 was shown to block
conductance of gap junction channels in paired Xenopus
laevis oocyte studies (Dahl et al, 1992), whereas replace-
ment of tryptophan 44 and arginine 75 not only interfered
with channel function but showed a dominant negative
effect on wild-type Cx26 (Richard et al, 1998; Martin et al,
1999; Rouan et al, 2001; Oshima et al, 2003). Some E1
mutants (C64S) were shown to interfere with protein folding
in the early phase of gap junction formation whereas others
(R75W) altered the structural stability of hexameric hemi-
channels (Oshima et al, 2003). Moreover, co-oligomerization
of different connexins into heteromeric connexons could
play an important role in disease pathogenesis. There is
mounting evidence that faulty hexamer formation or mem-
brane targeting of certain Cx26 mutants can be rescued by
wild-type Cx26 or Cx30, although the resulting channels are
defective, which has a (trans-)dominant negative effect on
intercellular communication (Marziano et al, 2003; Oshima
et al, 2003). Interference of aberrant mutant connexin sub-
units with the functional properties of homotypic or
heterotypic channels in which they are incorporated might
Figure 3
Immunostaining of Cx26, Cx30, and Cx43 in lesional palmar and knuckle skin of III-1. (a) Complete absence of Cx26 staining (green) in knuckle
skin and (d ) very weak staining in the spinous layers of palmar epidermis indicated by arrows but (e) normal punctate staining in epithelial cells of the
sweat ducts. (b) In contrast, Cx30 (red) is widely distributed throughout the granular and spinous layers. (c) Normal expression of Cx43 (red)
throughout the epidermis. Note that all connexins show the typical punctate pattern outlining the cell membranes, suggestive for gap junction
plaques. ( f ) Extensive co-localization of Cx26 and Cx30 in the sweat ducts. (g) Normal-appearing expression of Cx26 by the epithelium of an
eccrine sweat duct with punctate staining of the plasma membranes. Note the focal co-localization of Cx26 with Cx43 limited to suprabasal
keratinocytes surrounding the sweat duct. D, dermis; E, epidermis; sd, sweat duct; sg, sweat gland. Scale bar¼160 mm (a), 80 mm (b, c), 40 mm (d ),
30 mm (e, f ), and 60 mm (g).
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provide a possible mechanism contributing to the pleiotropy
and variable phenotypes of GJB2 mutations.
This assumption is supported by our results of connexin
immunostaining in lesional skin. In contrast to the cytoplas-
mic accumulation and defective trafficking of mutant con-
nexin proteins demonstrated in other disorders affecting
Cx26 (Martin et al, 1999; Marziano et al, 2003), Cx30 (Com-
mon et al, 2002), and Cx31 (Di et al, 2002), there was no
evidence for cytoplasmic clumping of Cx26 or other con-
nexins tested. The weak or absent Cx26 staining in palmar
and knuckle epidermis could indicate decreased stability of
mutant Cx26 transcripts or reduced synthesis of mutant
Cx26, yet Cx26 expression and distribution in eccrine sweat
glands and ducts appeared normal. We suspect that the
strong and more widespread expression of Cx30 in lesional
epidermis, which overlapped with that of Cx43, reflects
a compensatory mechanism to overcome aberrant Cx26
function. Although Cx30 overexpression could perhaps pre-
vent the trapping of mutant Cx26 in the cytoplasm as shown
experimentally (Marziano et al, 2003), hemichannels incor-
porating mutant Cx26 might be dysfunctional or fail to ag-
gregate into visible gap junction plaques. The precise
effects exerted by mutation N54K remain to be explored
as are the role of Cx26 in nail growth and leukonychia.
Materials and Methods
Patients and biological material We ascertained two affected
(II-1 and III-1) and one unaffected (II-2) persons from a three-gene-
rational family with BPS originating from Poland (Fig 1). Other
family members are living in Poland and could not be ascertained
for our study. DNA was collected from buccal swabs or venous
blood samples following standard procedures. Punch biopsy sam-
ples for light and electron microscopic examination were obtained
from the lesional skin (knuckle, palm) of individual III-1. The studies
were approved by the institutional review board and performed
with informed consent of all participants.
Mutation analysis The entire coding sequence of the human
connexin gene connexin-26 (GJB2; XM_007169) and flanking in-
tronic and 3’UTR sequences were amplified by PCR from genomic
DNA of affected individuals using the primers (sense) 50-GTTC
TGTCTTCACCTG-30 (nucleotides -170 to -155 from ATG transla-
tion start site) and (antisense) 50-TAACAGCCTGGGGTCTCAGT-30
(nucleotides 931 to 950). All PCR reactions were performed utiliz-
ing Taq DNA polymerase, 10% Q solution (Qiagen, Valencia, Cal-
ifornia) and standard PCR and cycling conditions (941C for 2 min;
35 cycles of 941C for 300 0, 571C for 450 0, 721C for 450 0, and finally
721C for 7 min). After agarose gel-purification (QIAquick gel ex-
traction kit, Qiagen), PCR fragments were directly sequenced using
the sense and antisense PCR primers listed above and the BigDye
terminator system on an ABI Prism 377 sequencer (PE Applied
Biosystems, Foster City, California). Using a similar approach,
the connexin genes GJB3, GJB4, GJB5, GJB6, and GJA1 were
screened for mutations as previously published (Richard et al,
2000, 2003b; Jan et al, 2004).
Using direct DNA sequencing and pyrosequencing (Pyrose-
quencing, Westborough, Massachusetts), we confirmed the nuc-
leotide transversion 162 C4A in the BPS family and excluded it
from 110 Caucasian control individuals without skin or hear-
ing disorder. In brief, PCR amplicons of 152 bp were generated
from genomic DNA using 10 pmol each of primer (sense)
50-GGCTCACCGTCCTCTTCATT-30 (nucleotides 71–90) and bioti-
nylated primer (antisense) 50-GATGTGGGAGATGGGGAAGT-30
(nucleotides 203–222), 1 U AmpliTaq Gold DNA polymerase (PE
Applied Biosystems, Foster City, California), and standard PCR and
cycling conditions for a 50-mL PCR reaction (951C for 12 min; 50
cycles of 941C for 150 0, 571C for 300 0, 721C for 300 0, and finally 721C
for 7 min). The PCR products were bound to streptavidin-coated
paramagnetic beads (Dynalbeads M280; Dynal, Norway). Single-
stranded immobilized, biotinylated DNA was obtained by incuba-
tion with 0.5 M NaOH for 1 min and resuspended in 45 mL of 1 
annealing buffer containing 10 pmol of sequencing primer 50-
CCGACTTTGTCTGCA-30 (bases 146–160), ending two nucleotides
upstream of the mutation site. Using a magnetic 96-pin manifold
(PSQ 96 Sample Preparation Tool; Pyrosequencing AB, Uppsala,
Sweden), the DNA-bead-reaction mixture containing DNA polym-
erase (exonuclease-deficient), apyrase, purified luciferase, ATP
sulfurylase, adenosine 50-phophosulfate, and luciferin was heated
at 801C for 2 min, cooled to room temperature, and automated
genotyping was performed at 281C in a pyrosequencing instrument,
PSQ96 (Pyrosequencing AB). Stepwise elongation of the primer
strand upon sequential addition of the different deoxynucleotide
triphosphates and the simultaneous degradation of nucleotides by
apyrase were carried out simultaneously and the sequence was
determined from the measured signal output of light upon nucleo-
tide incorporation. The resulting peaks in the pyrogram were analy-
zed using Pyrosequencing software (Pyrosequencing AB).
Immunohistochemistry Five micrometer-thick sections of
snap-frozen skin biopsies of lesional skin (left palm and knuckle,
individual III-1) and normal control skin were subjected to
immunohistochemical analyses as previously described (Rouan
et al, 2001). The primary monoclonal anti-Cx26 antibody (mouse;
Zymed Laboratories, San Francisco, California, Cat. #33-5800),
which does not cross-react with Cx30, was detected with fluo-
rescein-conjugated anti-mouse immunoglobulin. The polyclonal
anti-Cx43 and anti-Cx30 antibodies (rabbit, Zymed Laboratories)
were visualized with Texas Red-conjugated anti-rabbit immunoglo-
bin. Areas of focal co-localization of Cx26 with either Cx30 or Cx43
appear yellow. The analyses were performed in triplicate on a
Nikon TE 2000U fluorescent microscope using an Orca-100 digital
coolpix camera (Hamamatsu, Japan) and images were processed
in Adobe Photoshops (Adobe, San Jose, California).
Electron microscopy For transmission electron microscopy, a 2
mm knuckle skin sample was fixed in half-strength Karnovsky fix-
ative for 4 h, rinsed in 0.1 M cacodylate buffer pH 7.4, post-fixed
with 1% Osmium tetroxide, and embedded in Epon812 Taab,
Berkshire, UK). Ultrathin sections were cut and collected on form-
var-coated copper grids. Transmission electron microscopy was
performed as previously described (Ishida-Yamamoto et al, 1996).
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Appendix: Electronic–database information Accession
numbers and URLs for data in the article are as follows:
NCBI nucleotide database: http://www.ncbi.nlm.nih.gov:
80/entrez/query.fcgi?db=Nucleotide for accession numbers
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U43932, M86849, NT_024524 [GJB2]; AJ005585, NT_024524
[GJB6]; AL121988 [GJB4]; AF099730, AL121988 [GJB3];
NT_025741 [GJA1] and those listed in Fig 2b. The Connexin-
Deafness Homepage, http://www.crg.es/deafness/. Online
Mendelian Inheritance in Man, http://www3.ncbi.nlm.nih.
gov/entrez/query.fcgi?db=OMIM&cmd=Limits (OMIM; for
Bart–Pumphrey syndrome [149,200], Vohwinkel syndrome
[124,500], Keratitis-Ichthyosis-Deafness syndrome [148,210]).
BCM Search Launcher http://searchlauncher.bcm.tmc.edu/
multi-align/Options/clu stalw.html for multiple sequence align-
ments of human and mammalian connexin genes using
ClustalW.
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